We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Combination Drug Trial Launched to Eradicate B-Cell Malignancies

News   Mar 12, 2018 | Original story from UC San Diego

 
Combination Drug Trial Launched to Eradicate B-Cell Malignancies

Stained blood smear shows enlarged chronic lymphocytic leukemia cells among normal red blood cells. Credit: UC San Diego

 
 
 

RELATED ARTICLES

Hormone Therapy Battles Cognitive Decline

News

A new study has identified benefits of extended estrogen exposure and longer-term hormone therapy in combating cognitive decline

READ MORE

Harmful Gene Interactions Trigger Rare Form of GI Tumor

News

The "breakdown" of the normal 3D shape of DNA enables harmful interactions to form between genes in a rare type of gastrointestinal stromal tumors.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE